Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sotera Health (SHC)

Sotera Health Q3 revenue rises 4.4% to $324.9 million; full-year outlook reaffirmed

Positive Impact 3 of 5 earnings

Sotera Health reported third-quarter 2026 net revenues of $324.9 million, up 4.4% from $311.3 million a year earlier, and net income of $58.4 million, or $0.20 per diluted share, compared with $48.4 million, or $0.17, in the prior-year quarter. The company reaffirmed its full-year 2026 constant currency revenue and Adjusted EBITDA growth outlook, which means shareholders see steady profit growth with no change to expectations.

Key points

  • Q3 2026 net revenues were $324.9 million, up 4.4% from $311.3 million in Q3 2025.
  • Q3 2026 Adjusted EPS was $0.29, up 12% from $0.26 per diluted share a year earlier.
  • Full-year 2026 outlook reaffirmed: net revenue growth of 5.25% to 6.75% and Adjusted EBITDA growth of 5.75% to 7.25%, both on a constant currency basis.
  • Net leverage ratio was 2.9x as of September 30, 2026, compared with 3.2x at December 31, 2025.

The filing

CompanySotera Health (SHC)
Form8-K, current report
Filed with the SECNov 3, 2026, 8:11 AM ET
Accession number0001822479-26-000055

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.